Steven George Hughes
Chief Medical Officer · Atrium Therapeutics, Inc.
- 2025
- Sep 22, 2026
- 10
Summary
Latest filing:
Steven George Hughes is Chief Medical Officer of Atrium Therapeutics, Inc. (RNA). 10 SEC Form 4 filings on record going back to 2025, most recently on 22 September 2026. Most recent open-market trade: sold $209K of RNAM on 23 January 2026. Lifetime open-market sales: $4.27M.
Recent transactions
20The latest 20 SEC Form 4 transactions reported by Steven George Hughes.
Trading pattern
InsiderAlpha's records for Steven George Hughes go back to 2025: 10 primary Form 4 filings, an average of 5.0 per year. 5 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other insiders active in the same sector
No other insider has filed at Steven George Hughes's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven George Hughes?
Steven George Hughes is a corporate insider, tracked as Chief Medical Officer of Atrium Therapeutics, Inc. (RNA). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steven George Hughes submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Steven George Hughes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($4.27M) across all tracked filings.